Medicating Children With Attention Deficit Disorder

PEDIATRICS ◽  
1988 ◽  
Vol 82 (5) ◽  
pp. 812-812
Author(s):  
JERRY M. WIENER

To the Editor.— I read the position statement by the American Academy of Pediatrics, Committees on Children With Disabilities and Drugs (Pediatrics 1987;80:758-760) regarding medication for children with attention deficit disorder. It is encouraging that the American Academy of Pediatrics has undertaken to bring this information to its membership; it is disappointing that, in discussing evaluation and treatment, there was no acknowledgment of any role for the child psychiatrist, even though the vast majority of research into diagnosis and treatment has been done by child psychiatrists and published in the psychiatric literature.

PEDIATRICS ◽  
1988 ◽  
Vol 82 (5) ◽  
pp. 812-812
Author(s):  
HERBERT J. COHEN

In Reply.— The AAP Committee on Children With Disabilities concurs with several of the issues raised by Dr Wiener. We note the need for counseling for children with ADHD and clearly support referrals to child psychiatrists when these children need psychiatric help. We also agree that working with the family represents a major component of the treatment of children with ADHD. The selection of drugs such as methylphenidate over antidepressants represents our attempt to focus treatment on the use of this drug for ADHD itself.


PEDIATRICS ◽  
1995 ◽  
Vol 95 (1) ◽  
pp. 159-159
Author(s):  
Robert H. Chesky

As a private practitioner with some interest in periodic, standardized preschool developmental screening, I appreciated the recent position statement on this subject (Pediatrics, May 1994) by the Committee on Children with Disabilities. At least in my locale, it doesn't seem to me that we practicing pediatricians (myself included) have exactly covered ourselves with glory with respect to this important area of health supervision. Thus, perhaps pediatricians may benefit from "regular," "periodic," "formal" American Academy of Pediatrics reminders that inaccurate developmental assessments may deny preschool children needed (and now often publicly funded) early intervention and special education services.


PEDIATRICS ◽  
1986 ◽  
Vol 78 (5) ◽  
pp. 959-982
Author(s):  
Jerome O. Klein ◽  
Ralph D. Feigin ◽  
George H. McCracken

Children still die or suffer permanent neurologic sequelae as a result of bacterial meningitis. Prompt diagnosis and aggressive management are the goals, but early signs of meningitis are often subtle and nonspecific and, therefore, may be recognized only in retrospect. The physician must identify among the many febrile children seen every day in office practice—most of whom have spontaneously resolving illnesses usually caused by viruses—the few children who have serious bacterial infection requiring early intervention. No single test or battery of tests replaces the clinical acumen of the physician in identifying the child with early signs of bacterial meningitis. Because of controversies about diagnosis and treatment of meningitis voiced in various forums, including the courtroom, the Task Force on Diagnosis and Management of Meningitis has been asked by the Executive Board of the American Academy of Pediatrics to prepare a report on the causes, diagnosis, management, and outcome of meningitis in infants and children. This task force selected for discussion issues of current relevance and controversy in the diagnosis and treatment of bacterial and nonbacterial meningitis. Many other aspects of meningitis are discussed elsewhere. Commentaries on the prevention of disease by chemoprophylaxis (antimicrobial agents) or immunoprophylaxis (vaccines) have been prepared by the Committee on Infectious Diseases of the American Academy of Pediatrics. In addition the Morbidity and Mortality Weekly Report (Centers for Disease Control, Atlanta) publishes recommendations on vaccine usage and chemoprophylaxis formulated by the Advisory Committee on Immunization Practices. These resources are of value to the practitioner who cares for children and needs information on optimal measures for the treatment and prevention of meningitis.


2017 ◽  
Vol 132 (6) ◽  
pp. 654-659 ◽  
Author(s):  
Rachel L. Hulkower ◽  
Meghan Kelley ◽  
Lindsay K. Cloud ◽  
Susanna N. Visser

Objectives: In 2011, the American Academy of Pediatrics updated its guidelines for the diagnosis and treatment of children with attention-deficit/hyperactivity disorder (ADHD) to recommend that clinicians refer parents of preschoolers (aged 4-5) for training in behavior therapy and subsequently treat with medication if behavior therapy fails to sufficiently improve functioning. Data available from just before the release of the guidelines suggest that fewer than half of preschoolers with ADHD received behavior therapy and about half received medication. About half of those who received medication also received behavior therapy. Prior authorization policies for ADHD medication may guide physicians toward recommended behavior therapy. Characterizing existing prior authorization policies is an important step toward evaluating the impact of these policies on treatment patterns. We inventoried existing prior authorization policies and characterized policy components to inform future evaluation efforts. Methods: A 50-state legal assessment characterized ADHD prior authorization policies in state Medicaid programs. We designed a database to capture data on policy characteristics and authorization criteria, including data on age restrictions and fail-first behavior therapy requirements. Results: In 2015, 27 states had Medicaid policies that prevented approval of pediatric ADHD medication payment without additional provider involvement. Seven states required that prescribers indicate whether nonmedication treatments were considered before Medicaid payment for ADHD medication could be approved. Conclusion: Medicaid policies on ADHD medication treatment are diverse; some policies are tied to the diagnosis and treatment guidelines of the American Academy of Pediatrics. Evaluations are needed to determine if certain policy interventions guide families toward the use of behavior therapy as the first-line ADHD treatment for young children.


1985 ◽  
Vol 30 (4) ◽  
pp. 265-269 ◽  
Author(s):  
J.H. Kashani ◽  
J.P. Burk ◽  
J.C. Reid

Fifty children whose parents had a diagnosis of affective disorder were given a stuctured diagnostic interview by a child psychiatrist. The parents were also interviewed about their children. Fourteen per cent of the children were found to be depressed. Compared to the remaining children, the depressed children endorsed significantly more symptoms of attention deficit disorder, oppositional disorder, mania, overanxious disorder, phobia, and bulima in the interview. The parent's interview disclosed that the depressed children were abused significantly more than the non-depressed group.


Sign in / Sign up

Export Citation Format

Share Document